198 related articles for article (PubMed ID: 15481152)
21. Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor.
Seno A; Maruhashi T; Kaifu T; Yabe R; Fujikado N; Ma G; Ikarashi T; Kakuta S; Iwakura Y
Exp Anim; 2015; 64(2):109-19. PubMed ID: 26176030
[TBL] [Abstract][Full Text] [Related]
22. DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway.
Lambert AA; Barabé F; Gilbert C; Tremblay MJ
Blood; 2011 Jun; 117(24):6589-99. PubMed ID: 21536857
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of transcripts for the autoimmunity-related human dendritic cell immunoreceptor.
Ronninger M; Eklöw C; Lorentzen JC; Klareskog L; Padyukov L
Genes Immun; 2008 Jul; 9(5):412-8. PubMed ID: 18480830
[TBL] [Abstract][Full Text] [Related]
24. Cloning and characterization of a novel ITIM containing lectin-like immunoreceptor LLIR and its two transmembrane region deletion variants.
Huang X; Yuan Z; Chen G; Zhang M; Zhang W; Yu Y; Cao X
Biochem Biophys Res Commun; 2001 Feb; 281(1):131-40. PubMed ID: 11178971
[TBL] [Abstract][Full Text] [Related]
25. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
Jähn PS; Zänker KS; Schmitz J; Dzionek A
Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cell immunoreceptor is a new target for anti-AIDS drug development: identification of DCIR/HIV-1 inhibitors.
Lambert AA; Azzi A; Lin SX; Allaire G; St-Gelais KP; Tremblay MJ; Gilbert C
PLoS One; 2013; 8(7):e67873. PubMed ID: 23874461
[TBL] [Abstract][Full Text] [Related]
27. Efficient generation of a monoclonal antibody against the human C-type lectin receptor DCIR by targeting murine dendritic cells.
Heidkamp GF; Neubert K; Haertel E; Nimmerjahn F; Nussenzweig MC; Dudziak D
Immunol Lett; 2010 Aug; 132(1-2):69-78. PubMed ID: 20566350
[TBL] [Abstract][Full Text] [Related]
28. Recognition of Mycobacteria by Dendritic Cell Immunoactivating Receptor.
Toyonaga K; Yamasaki S
Curr Top Microbiol Immunol; 2020; 429():103-115. PubMed ID: 32300915
[TBL] [Abstract][Full Text] [Related]
29. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways.
Lambert AA; Gilbert C; Richard M; Beaulieu AD; Tremblay MJ
Blood; 2008 Aug; 112(4):1299-307. PubMed ID: 18541725
[TBL] [Abstract][Full Text] [Related]
30. Human NKG2F is expressed and can associate with DAP12.
Kim DK; Kabat J; Borrego F; Sanni TB; You CH; Coligan JE
Mol Immunol; 2004 May; 41(1):53-62. PubMed ID: 15140575
[TBL] [Abstract][Full Text] [Related]
31. Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood.
Van Brussel I; Van Vré EA; De Meyer GR; Vrints CJ; Bosmans JM; Bult H
J Immunol Methods; 2010 Oct; 362(1-2):168-75. PubMed ID: 20888334
[TBL] [Abstract][Full Text] [Related]
32. The C-type lectin receptor DCIR is crucial for the development of experimental cerebral malaria.
Maglinao M; Klopfleisch R; Seeberger PH; Lepenies B
J Immunol; 2013 Sep; 191(5):2551-9. PubMed ID: 23918990
[TBL] [Abstract][Full Text] [Related]
33. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
McVicar DW; Burshtyn DN
Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
[TBL] [Abstract][Full Text] [Related]
34. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
Soilleux EJ
Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells.
Massoud AH; Yona M; Xue D; Chouiali F; Alturaihi H; Ablona A; Mourad W; Piccirillo CA; Mazer BD
J Allergy Clin Immunol; 2014 Mar; 133(3):853-63.e5. PubMed ID: 24210883
[TBL] [Abstract][Full Text] [Related]
36. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells.
Fujikado N; Saijo S; Yonezawa T; Shimamori K; Ishii A; Sugai S; Kotaki H; Sudo K; Nose M; Iwakura Y
Nat Med; 2008 Feb; 14(2):176-80. PubMed ID: 18204462
[TBL] [Abstract][Full Text] [Related]
37. Enhancing immune responses by targeting antigen to DC.
Caminschi I; Lahoud MH; Shortman K
Eur J Immunol; 2009 Apr; 39(4):931-8. PubMed ID: 19197943
[TBL] [Abstract][Full Text] [Related]
38. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
Saeland E; van Vliet SJ; Bäckström M; van den Berg VC; Geijtenbeek TB; Meijer GA; van Kooyk Y
Cancer Immunol Immunother; 2007 Aug; 56(8):1225-36. PubMed ID: 17195076
[TBL] [Abstract][Full Text] [Related]
39. C-type lectins on dendritic cells: key modulators for the induction of immune responses.
van Kooyk Y
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1478-81. PubMed ID: 19021579
[TBL] [Abstract][Full Text] [Related]
40. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future.
Daëron M; Jaeger S; Du Pasquier L; Vivier E
Immunol Rev; 2008 Aug; 224():11-43. PubMed ID: 18759918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]